GOOGLE has made limited changes to its advertising policies to allow CBD topicals to be promoted on its platforms in
THE German cannabis industry, patients groups and doctors have launched a fightback against proposals which would have a detrimental impact
AS Brains Bioceuticals unveiled a significant expansion of its UK production facilities, it has warned that any future investment is
CONCERNS the creation of an adult-use cannabis market will contravene international law have been dismissed by senior members of the
A NEW national survey of 4,000 people has highlighted the need to improve awareness of cannabis as a medicine. Key
FOLLOWING last week’s rally there has seen something of a lull with little movement for European cannabis stocks. Last week’s
A THREE-YEAR neuropathic pain (pre-clinical) study by Cannasouth has confirmed that cannabinoids from medicinal cannabis could be effective at reducing
CANNABIS extraction and formulations specialist 113 Botanicals is in the process of securing Good manufacturing Practice (GMP) compliance for its
A FIRST for the UK this week with the announcement that a major study into the potential benefits of cannabis
OXFORD Cannabinoid Technologies Holdings plc (LSE: OCTP, OTCQB: OCTHF), the pharmaceutical company developing prescription cannabinoid medicines targeting the US$ multi-billion
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
